Form 4: Capricor EVP Exercises Stock Options, Boosts Stake

Karen Krasney, Capricor Therapeutics' EVP and General Counsel, exercised 2,500 stock options at $1.39 per share, increasing her direct beneficial ownership to 30,547 common shares.

Summary

• Karen Krasney, Executive Vice President and General Counsel of Capricor Therapeutics, Inc. (CAPR), exercised 2,500 stock options.
• The transaction occurred on December 30, 2025.
• The exercise price for the common stock was $1.39 per share.
• Following the transaction, Ms. Krasney directly beneficially owns 30,547 shares of Capricor Therapeutics Common Stock.
• The exercised options were originally granted on January 3, 2017, and were adjusted to reflect a 1-for-10 reverse stock split on June 4, 2019, and a reprice to $1.39 per share on February 12, 2020.
• The options vested 1/48th on the first day of each month commencing February 1, 2017, and have an expiration date of January 3, 2027.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as an executive increasing their direct ownership through option exercise typically reflects confidence in the company's future performance and valuation.

Positives

• An executive exercising stock options indicates confidence in the company's future prospects at the exercise price.
• The increase in direct beneficial ownership by a key executive aligns management's interests with those of shareholders.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly option exercises that increase an executive's direct stake, are often viewed by the market as a positive signal, suggesting management's belief in the company's long-term value, especially in the biotechnology sector where future pipeline success is critical.

Stakeholder Impact

• Shareholders: May interpret the executive's increased stake as a positive indicator of management confidence and alignment of interests.
• Employees: Could view this as a sign of stability and belief in the company's future from leadership.

Key Dates

Recommendation

The exercise of stock options by a key executive, increasing their direct beneficial ownership, is generally a positive signal indicating management's confidence in the company's future. However, a single insider transaction, without broader financial or strategic updates, is typically not sufficient to warrant a 'buy' recommendation, but rather reinforces a 'hold' position for existing investors or suggests further due diligence for potential investors.

Keywords

Capricor Therapeutics, CAPR, Insider Transaction, Stock Option Exercise, Karen Krasney, EVP General Counsel, Beneficial Ownership, SEC Form 4